Active	Status	Sponsor type	Region	Phase	Filter
2 Active 8 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
YPI 011 / KT&G Corp
NCT04703868: A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects	Completed	1	88	RoW	Rabeprazole Sodium 10mg, Reference drug, Rabeprazole Sodium 20mg	Yungjin Pharm. Co., Ltd., Seoul National University Hospital	Gastroesophageal Reflux Disease	06/21	06/21
2-isopropyl-3H-naphtho[2,1-d]imidazole-4,5-dione (KL1333) / Abliva, KT&G Corp
FALCON, NCT05650229 / 2021-002846-33: Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Recruiting	2	180	Europe, US	KL1333, Placebo	Abliva AB	Primary Mitochondrial Disease	10/27	11/27
NM-401 / Neuramedy, KT&G Corp
No trials found
NM-402 / KT&G Corp, Neuramedy
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
YPI 011 / KT&G Corp
NCT04703868: A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects	Completed	1	88	RoW	Rabeprazole Sodium 10mg, Reference drug, Rabeprazole Sodium 20mg	Yungjin Pharm. Co., Ltd., Seoul National University Hospital	Gastroesophageal Reflux Disease	06/21	06/21
2-isopropyl-3H-naphtho[2,1-d]imidazole-4,5-dione (KL1333) / Abliva, KT&G Corp
FALCON, NCT05650229 / 2021-002846-33: Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Recruiting	2	180	Europe, US	KL1333, Placebo	Abliva AB	Primary Mitochondrial Disease	10/27	11/27
NM-401 / Neuramedy, KT&G Corp
No trials found
NM-402 / KT&G Corp, Neuramedy
No trials found